Clinical trial

Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine…

NCT00136851 · Novartis Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00136851
Title Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
Official title A 6-Week Multi-center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
Lead sponsor Novartis Pharmaceuticals, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hypertension
Intervention type Drug
Interventions amlodipine besylate/benazepril hydrochloride
Enrollment 259
Start date Dec 1, 2004
Primary completion Jul 1, 2005
Completion Jul 1, 2005
First posted Aug 29, 2005
Last update posted Nov 8, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies